Physician profile
Amy Young
NPI 1770571820
$3,480.05
in general payments reported to CMS, 2019-2025
25 companies · $78.28 in 2025
The $78.28 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $888 · 2022: $834 · 2023: $949 · 2024: $732 · 2025: $78.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $752.00 | 2021-2024 | Proclaim, Octrode, Eterna |
| Nevro Corp. | $341.62 | 2021-2023 | Senza |
| Saluda Medical Americas, INC. | $266.70 | 2024-2025 | Evoke |
| Boston Scientific Corporation | $260.78 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $221.69 | 2023-2024 | Mild Device Kit |
| Medtronic, INC. | $221.37 | 2022-2023 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $179.12 | 2022-2023 | Relistor |
| Hikma Pharmaceuticals USA | $146.33 | 2021-2022 | |
| Relievant Medsystems, INC. | $143.53 | 2023 | Intracept |
| Avanos Medical | $141.88 | 2021-2023 | Trivisc Sodium Hyaluronate |
| Collegium Pharmaceutical, INC. | $123.32 | 2021-2024 | Xtampza |
| Protega Pharmaceutials INC | $94.43 | 2023-2024 | Roxybond |
| Tersera Therapeutics LLC | $86.25 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $82.36 | 2021 | |
| Ibsa Pharma INC. | $67.24 | 2023-2025 | Tirosint, Tirosint, Licart |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $66.39 | 2021-2022 | |
| Spr Therapeutics, INC | $55.32 | 2022-2023 | Sprint Pns System |
| Allergan, INC. | $50.01 | 2021 | |
| Alfasigma USA, INC. | $38.45 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $32.55 | 2024 | |
| Grt US Holding, INC. | $32.00 | 2022 | |
| Fidia Pharma USA INC. | $26.77 | 2022 | |
| Nalu Medical, INC. | $19.99 | 2024 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $17.67 | 2025 | Ha Minuteman G3-R |
| Novartis Pharmaceuticals Corporation | $12.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.